Patent details

EP3221359 Title: METHODS FOR TUMOR TREATMENT USING CD3XCD20 BISPECIFIC ANTIBODY

Basic Information

Publication number:
EP3221359
PCT Application Number:
US2015061139
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP158016378
PCT Publication Number:
WO2016081490
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS FOR TUMOR TREATMENT USING CD3XCD20 BISPECIFIC ANTIBODY
French Title of Invention:
PROCÉDÉS POUR LE TRAITEMENT DE TUMEURS À L'AIDE DE CD3XCD20 ANTICORPS BISPÉCIFIQUES
German Title of Invention:
VERFAHREN ZUR TUMORBEHANDLUNG MIT BISPEZIFISCHEM ANTIKÖRPER CD3XCD20
SPC Number:

Dates

Filing date:
17/11/2015
Grant date:
27/05/2020
EP Publication Date:
27/09/2017
PCT Publication Date:
26/05/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/05/2020
EP B1 Publication Date:
27/05/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/11/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/05/2020
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
29/05/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LOWY, Israel
Address:
United States (US)

2

Name:
SMITH, Eric
Address:
United States (US)

3

Name:
KIRSHNER, Jessica R.
Address:
United States (US)

4

Name:
THURSTON, Gavin
Address:
United States (US)

5

Name:
BROWNSTEIN, Carrie
Address:
United States (US)

6

Name:
DAVIS, Samuel
Address:
United States (US)

7

Name:
VARGHESE, Bindu
Address:
United States (US)

Priority

1

Priority Number:
201462080716 P
Priority Date:
17/11/2014
Priority Country:
United States (US)

2

Priority Number:
201562160788 P
Priority Date:
13/05/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61P 35/02; C07K 16/28; G01N 33/50;

Publication

European Patent Bulletin

Issue number:
202022
Publication date:
27/05/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
22/10/2024
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
29/05/2020 Outgoing Correspondence 1
29/05/2020 Power Of Attorney 1